Amphastar Pharmaceuticals, Inc. Operating Lease, Liability, Current
Financial Statements › Balance Sheet › Liabilities › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Current $8.80M.
- 2026-03-31: Operating Lease, Liability, Current $9.71M.
- 2025-12-31: Operating Lease, Liability, Current $7.93M.
- 2025-09-30: Operating Lease, Liability, Current $7.83M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $8.80M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $9.71M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $7.93M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $7.83M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $7.88M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $7.75M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $6.80M 10-K · filed 2026-02-26 |
| 2024-09-30 | $4.21M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $4.00M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $3.94M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $3.91M 10-K · filed 2025-03-03 |
| 2023-09-30 | $3.72M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $3.13M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $2.99M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $3.00M 10-K · filed 2024-02-29 |
| 2022-09-30 | $3.18M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $3.31M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $3.28M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $2.98M 10-K · filed 2023-03-01 |
| 2021-09-30 | $2.86M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $3.24M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $3.70M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $3.36M 10-K · filed 2022-03-11 |
| 2020-09-30 | $3.64M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $3.48M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $3.48M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $3.17M 10-K · filed 2021-03-15 |
| 2019-09-30 | $3.09M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $2.74M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $2.56M 10-Q · filed 2019-05-10 |